Beijing Tianxing is a clinical solutions company specializing in sports medicine, offering innovative implants, arthroscopy devices, and sports medicine equipment. The company, founded in 2017, operates within the Health Care, Medical Devices, and Sports industries. Its recent Series B investment, secured on January 1, 2022, saw participation from prominent investors including OrbiMed, Legend Capital, and 3W Partners. Their pioneering approach to advanced clinical solutions in sports medicine positions the company at the forefront of the industry. With a focus on innovation, Beijing Tianxing aims to make a lasting impact in the field of sports medicine.
No recent news or press coverage available for Beijing Tianxing.